1. Vane, J. R.; Botting, R. M.Therapeutic Roles of Selective COX-2Inhibitors; William Harvey Press: London, UK, 2001; pp 1−548.
2. Ford-Hutchinson, A. W. Evidence for the Involvement of Leukotrienes and Other Lipoxygenase Products in Disease States. Chapter 5.Leukotrienes and Lipoxygenases: Chemical, Biological and ClinicalAspects; Rokach, J., Ed.; Elsevier Press: Amsterdam, 1989; pp 407−410.